Myocardial injury | Mortality at 28 days | Mortality at 7 days | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
LR+ | Given positive test pre/posttest odds | LR- | Given negative test pre/posttest odds | LR+ | Given positive test pre/posttest odds | LR- | Given negative test pre/posttest odds | LR+ | Given positive test pre/posttest odds | LR- | Given negative test pre/posttest odds | |
MR-proADM | 3.03 | 1.24/3.76 | 0.52 | 1.24/0.64 | 2.03 | 0.39/0.79 | 0.33 | 0.39/0.13 | 4.3 | 0.23/0.99 | 0.13 | 0.23/0.03 |
(1.18, 7.76) | (0.32, 0.86) | (1.269, 3.236) | (0.116, 0.939) | (2.32, 7.97) | (0.02, 0.82) | |||||||
CT-proET-1 | 3.39 | 1.24/4.20 | 0.25 | 1.24/0.31 | 1.79 | 0.39/0.70 | 0.46 | 0.39/0.14 | 2.01 | 0.23/0.46 | 0.46 | 0.23/0.11 |
(1.54, -7.46) | (0.11, 0.57) | (1.158, 2.762) | (0.233, 0.987) | (1.13, 3.57) | (0.17, 1.22) | |||||||
hsTNT | - | - | - | - | 3.20 | 0.35/1.12 | 0.39 | 0.35/0.14 | 2.86 | 0.19/0.54 | 0.34 | 0.19/0.07 |
(1.570, 6.529) | (0.171, 0.903) | (1.50, 5.47) | (0.10, 1.14) | |||||||||
MR-proADM and CT-proET-1 | 12 | 1.24/14.9 | 0.44 | 1.24/0.55 | 2.14 | 0.39/0.84 | 0.27 | 0.39/0.10 | 5.02 | 0.23/1.15 | 0.17 | 0.23/0.04 |
(1.74, 84) | (0.28, 0.70) | (1.25, 3.67) | (0.07, 1.01) | (1.95, 9.47) | (0.02, 1.04) | |||||||
MR-proADM, CT-proET-1 and hsTNT | - | - | - | - | 19.92 | 0.35/6.97 | NA* | NA* | 13.13 | 0.19/2.49 | NA* | NA* |
(2.70, 146.88) | (3.06, 56.24) |